Adamas Pharmaceuticals Inc (25) | Business Finance (8)

Browse by Subcategory

Recent Contracts

First Amendment to Asset Purchase Agreement by and between Adamas Pharmaceuticals, Inc. and Osmotica Pharmaceutical US LLC (Filed With SEC on August 9, 2021)
Binding Term Sheet by and between Adamas Pharma, LLC and Zydus Worldwide DMCC and Zydus Pharmaceuticals (USA) Inc (Filed With SEC on May 10, 2021)
Underwriting Agreement, dated February 24, 2021, by and between the Company and SVB Leerink LLC and William Blair & Company, L.L.C., as representatives of the underwriters named... (Filed With SEC on February 25, 2021)
Amendment No. 3 to the Loan Agreement dated December 1, 2020 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P (Filed With SEC on February 23, 2021)
Description of Capital Stock (Filed With SEC on February 25, 2020)
Asset Purchase Agreement by and between Adamas Pharmaceuticals, Inc. and Osmotica Pharmaceutical US LLC (Filed With SEC on February 23, 2021)
Amendment No. 2 to the Loan Agreement dated January 2, 2020 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P (Filed With SEC on February 25, 2020)
Binding Term Sheet by and between Adamas Pharma, LLC and Sandoz, Inc (Filed With SEC on February 25, 2020)